In contrast, long term follow-up results from the randomized, placebo-controlled Women’s Health Initiative (WHI) trials in post-menopausal women showed that the use of estrogen alone as a menopausal hormone therapy decreased breast cancer incidence and death for patients with both ERα+ disease and TNBC13,14. The gene discussed is ESR1; the disease is breast carcinoma.